Phase 1 Study of huCART19-IL18-CD428z Cells for the Treatment of Patients With HIV With CD19+ Cancers

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This research study is being conducted to evaluate an experimental drug called huCART19-IL18-CD428z cells in patients living with HIV who have been diagnosed with Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Acute Lymphoblastic Leukemia (ALL), and Richter\'s Transformation (RT).
Epistemonikos ID: 286b7a8023df9805d073a5a0fe9a77c86d69fc77
First added on: Oct 24, 2026